Maryland Oncology Hematology (MOH) ( Site 8102) — Rockville, Maryland

Maryland Oncology Hematology (MOH) ( Site 8102) is a clinical research site located in Rockville, Maryland, United States 20850.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Maryland Oncology Hematology (MOH) ( Site 8102) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rockville

Browse all research sites in Maryland · View every site in Rockville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Maryland Oncology Hematology (MOH) ( Site 8102)?

Maryland Oncology Hematology (MOH) ( Site 8102) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Maryland Oncology Hematology (MOH) ( Site 8102) conducted?

Maryland Oncology Hematology (MOH) ( Site 8102) has 1 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Non-Small-Cell Lung.

Is Maryland Oncology Hematology (MOH) ( Site 8102) accredited by Crixeo Clinical Trials?

Maryland Oncology Hematology (MOH) ( Site 8102) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Maryland Oncology Hematology (MOH) ( Site 8102)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.